Raisman-Vozari R - Search Results

1

Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.

Bortolanza M, Nascimento GC, Socias SB, Ploper D, Chehín RN, Raisman-Vozari R, Del-Bel E. Bortolanza M, et al. J Neural Transm (Vienna). 2018 Oct;125(10):1403-1415. doi: 10.1007/s00702-018-1913-1. Epub 2018 Aug 14. J Neural Transm (Vienna). 2018. PMID: 30109452 Review.

2

Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.

Salum C, Raisman-Vozari R, Michel PP, Gomes MZ, Mitkovski M, Ferrario JE, Ginestet L, Del Bel EA. Salum C, et al. Brain Res. 2008 Mar 10;1198:27-33. doi: 10.1016/j.brainres.2007.12.054. Epub 2008 Jan 3. Brain Res. 2008. PMID: 18255050

3

A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.

Gomes MZ, Raisman-Vozari R, Del Bel EA. Gomes MZ, et al. Brain Res. 2008 Apr 8;1203:160-9. doi: 10.1016/j.brainres.2008.01.088. Epub 2008 Feb 13. Brain Res. 2008. PMID: 18313645

4

Altered expression of neuronal nitric oxide synthase in weaver mutant mice.

Cavalcanti-Kwiatkoski R, Raisman-Vozari R, Ginestet L, Del Bel E. Cavalcanti-Kwiatkoski R, et al. Brain Res. 2010 Apr 22;1326:40-50. doi: 10.1016/j.brainres.2010.02.056. Epub 2010 Feb 25. Brain Res. 2010. PMID: 20219442 Free article.

5

Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease.

Prediger RD, Rojas-Mayorquin AE, Aguiar AS Jr, Chevarin C, Mongeau R, Hamon M, Lanfumey L, Del Bel E, Muramatsu H, Courty J, Raisman-Vozari R. Prediger RD, et al. J Neural Transm (Vienna). 2011 Aug;118(8):1215-25. doi: 10.1007/s00702-010-0568-3. Epub 2011 Feb 8. J Neural Transm (Vienna). 2011. PMID: 21301897

6

Role of nitric oxide in motor control: implications for Parkinson's disease pathophysiology and treatment.

Del-Bel E, Padovan-Neto FE, Raisman-Vozari R, Lazzarini M. Del-Bel E, et al. Curr Pharm Des. 2011;17(5):471-88. doi: 10.2174/138161211795164176. Curr Pharm Des. 2011. PMID: 21375483 Review.

7

New strategies in neuroprotection and neurorepair.

Antonelli MC, Guillemin GJ, Raisman-Vozari R, Del-Bel EA, Aschner M, Collins MA, Tizabi Y, Moratalla R, West AK. Antonelli MC, et al. Neurotox Res. 2012 Jan;21(1):49-56. doi: 10.1007/s12640-011-9265-8. Epub 2011 Aug 23. Neurotox Res. 2012. PMID: 21861211 Free PMC article. Review.

8

Characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase early amyloid-like oligomers and their implication in α-synuclein aggregation.

Torres-Bugeau CM, Ávila CL, Raisman-Vozari R, Papy-Garcia D, Itri R, Barbosa LR, Cortez LM, Sim VL, Chehín RN. Torres-Bugeau CM, et al. J Biol Chem. 2012 Jan 20;287(4):2398-409. doi: 10.1074/jbc.M111.303503. Epub 2011 Dec 1. J Biol Chem. 2012. PMID: 22134915 Free PMC article.

9

Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression.

Padovan-Neto FE, Ferreira NR, de Oliveira-Tavares D, de Aguiar D, da Silva CA, Raisman-Vozari R, Del Bel E. Padovan-Neto FE, et al. Neurosci Lett. 2013 Apr 29;541:126-31. doi: 10.1016/j.neulet.2013.02.015. Epub 2013 Feb 18. Neurosci Lett. 2013. PMID: 23428503 Free article.

10

Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in mice, an experimental model of Parkinson's disease.

Tristão FS, Amar M, Latrous I, Del-Bel EA, Prediger RD, Raisman-Vozari R. Tristão FS, et al. Neurotox Res. 2014 Jan;25(1):24-32. doi: 10.1007/s12640-013-9401-8. Epub 2013 May 21. Neurotox Res. 2014. PMID: 23690159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page